4 Biotechs Facing Do-or-Die Catalysts in December Post author:Sam Post published:December 5, 2017 Post category:BioPharma As 2018 winds down, it’s not over for some biopharma companies. Source: BioSpace You Might Also Like Ardelyx Shares Soared After Positive Phase III Results for Tenapanor October 11, 2017 2017 Global CESI-MS Symposium Hosted By SCIEX To Be Held In Boston September 25, 2017 Bay Area's AirXpanders Bags $34 Million In Private Placement January 29, 2017
